MoneyWorks4Me

Syschem (India) informs about press release

12 Mar 2024 Evaluate
Syschem (India) has informed that newspaper advertisement for remote e-voting are published in Jansatta (Hindi) and Business Standard (Chandigarh, Delhi) regarding the remote e-voting facility available to members and to register their mailing id if not registered till date.

The above information is a part of company’s filings submitted to BSE.

Syschem (India) Share Price

32.19 0.17 (0.53%)
25-Aug-2026 11:43 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1916.25
Dr. Reddys Labs. 1186.65
Cipla 1420.00
Lupin 2170.55
Zydus Lifesciences 1095.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: